PAPER Veljanoska E, Gomes S, Szende A, Cabra A, Munter-Young R, Gordois A

The Value of Positron Emission Tomography for Confirmation of Alzheimer's Disease in the Era of Amyloid-Targeting Therapies.

Value Health. 2025 Mar 5; Epub 2025 Mar 5 PubMed.

PAPER Zheng M

Snapshot of disease continuum centered on Alzheimer's disease: Exploring modifiable risk factors.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Mar 5;138:111316. Epub 2025 Mar 5 PubMed.

PAPER Chen H, Fang Z, Lin SL, Schachner M

L1CAM mimetic compound duloxetine improves cognitive impairment in 5xFAD mice and protects Aβ1-42-damaged HT22 cells.

Eur J Pharmacol. 2025 Mar 6;997:177476. Epub 2025 Mar 6 PubMed.

PAPER Elliott C, Jackson J, Findlay J, Williams G, Ghosh A, Ribe E, Ulmschneider M, Khan A, Ballard C, Aarsland D, Baillie GS, Harte M, Killick R

Blocking the Dkk1-LRP6 interaction prevents acute amyloid-β-driven cognitive impairment.

Cell Signal. 2025 Mar 6;131:111716. Epub 2025 Mar 6 PubMed.

PAPER Shahid F, Khan R, Mehmood A, Smadi AA, Ibrahim MM, Zheng Z

A Comprehensive Approach to Anticipating the Progression of Mild Cognitive Impairment.

Brain Res. 2025 Mar 6;:149549. Epub 2025 Mar 6 PubMed.

PAPER Kicik A, Kurt E, Hari E, Ulasoglu-Yildiz Ç, Gurvit H, Demiralp T

Impact of amygdala functional connectivity on cognitive impairment in Alzheimer's disease.

Neurol Sci. 2025 Mar 8; Epub 2025 Mar 8 PubMed.

PAPER Yu J, Zhou R, Liu S, Zheng J, Yan H, Su S, Chai N, Segal E, Jiang C, Guo K, Li CZ

Electrochemical Biosensors for the Detection of Exosomal microRNA Biomarkers for Early Diagnosis of Neurodegenerative Diseases.

Anal Chem. 2025 Mar 9; Epub 2025 Mar 9 PubMed.

PAPER Mitra J, Kodavati M, Dharmalingam P, Guerrero EN, Rao KS, Garruto RM, Hegde ML

Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence.

Acta Neuropathol Commun. 2025 Mar 8;13(1):54. PubMed.

PAPER Vostrý M, Chytrý V, Cmorej PC, Fleischmann O, Kubová N

Effect of combined and intensive rehabilitation on cognitive function in patients with Alzheimer's disease evaluated through a randomized controlled trial.

Sci Rep. 2025 Mar 8;15(1):8110. PubMed.

PAPER Guo J, Wang P, Gong J, Sun W, Han X, Xu C, Shan A, Wang X, Luan H, Li S, Li R, Wen B, Chen R, Lv S, Wei C

The disease burden, risk factors and future predictions of Alzheimer's disease and other types of dementia in Asia from 1990 to 2021.

J Prev Alzheimers Dis. 2025 Mar 7;:100122. Epub 2025 Mar 7 PubMed.

PAPER Leroy M, Aziz AL, Schraen S, Deramecourt V, Skrobala E, Lecerf S, Pasquier F, Huin V, Bertoux M, Lebouvier T

Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysis.

Rev Neurol (Paris). 2025 Mar 7; Epub 2025 Mar 7 PubMed.

PAPER Zhang C, Xu J, Xu F, Xie X, Ji T, Wang C, Du J

1-Epilupinine enhances cognition and reduces inflammation in scopolamine-induced dementia model mice.

Neurosci Lett. 2025 Mar 6;852:138184. Epub 2025 Mar 6 PubMed.

PAPER Zhang B, Chen L, Kang M, Ai L, Tao Y

Gegen Qinlian Decoction improves Alzheimer's disease through TLR4/NF-κB/NLRP3 pathway.

Tissue Cell. 2025 Mar 1;95:102818. Epub 2025 Mar 1 PubMed.

PAPER Singh-Reilly N, Pham NT, Graff-Radford J, Machulda MM, Spychalla AJ, Senjem ML, Petersen RC, Lowe VJ, Boeve BF, Jack CR Jr, Josephs KA, Kantarci K, Whitwell JL

White matter hyperintensities in dementia with lewy bodies and posterior cortical atrophy.

Neurobiol Aging. 2025 Mar 3;150:44-52. Epub 2025 Mar 3 PubMed.

PAPER Ordoñez WO, Palomino NV, Varela PE, Martínez IB, Alves LB, Giuliatti S

Alkaloids from Caliphruria subedentata (Amaryllidaceae) as Regulators of AChE, BuChE, NMDA and GSK3 Activity: An In Vitro and In Silico Approach for Mimicking Alzheimer´s Disease.

Neurochem Res. 2025 Mar 8;50(2):116. PubMed.